This article needs additional citations for
verification. (February 2022) |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.067.969 |
Chemical and physical data | |
Formula | C18H20N2O2 |
Molar mass | 296.370 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Vinconate is a synthetic vincamine analog used as a nootropic. [1]
Vinconate, even when systemically administered, enhances the endogenous release of dopamine in the striatum, probably via the stimulation of presynaptic muscarinic receptors. [2]
This article needs additional citations for
verification. (February 2022) |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.067.969 |
Chemical and physical data | |
Formula | C18H20N2O2 |
Molar mass | 296.370 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Vinconate is a synthetic vincamine analog used as a nootropic. [1]
Vinconate, even when systemically administered, enhances the endogenous release of dopamine in the striatum, probably via the stimulation of presynaptic muscarinic receptors. [2]